Floatz logo

Flurbiprofen Axetil

Delirium

Peking University First HospitalPhase 4 / ApprovedDormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
39/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Delirium cohort.

Asset / SponsorPhaseRating
PROPOFOL
RenJi Hospital
Phase 4BB
ISOFLURANE
Duke University
Phase 4BB
Suvorexant
Mayo Clinic
Phase 4BB
Clonidine
Insel Gruppe AG, University Hospital Bern
Phase 4BB
Cyclopofol
RenJi Hospital
Phase 4BB

View all 23 →

Same molecule, other indications

Flurbiprofen Axetil is also rated in:

Enhanced Recovery After SurgeryDormant
B
Indicative ·
56 / 100
View asset →
Multimodal AnalgesiaDormant
B
Indicative ·
56 / 100
View asset →
DexamethasoneDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →